Marc Beer has been leading innovative companies in the medical field since the 1990s. During this time, these companies have developed and marketed several different products that have changed the lives of those who take them. While he may not be the one who is actually creating these treatments and devices, he is responsible for things such as securing funding. As the Chief Executive Officer of Renovia, a company that was launched in 2016, he has already seen one of their products get approved and marketed for pelvic floor disorder and are expecting more to get approval in the near future. Not only is Marc Beer the Chief Executive Officer of Renovia, but he is also a co-founder of the company that focuses on pelvic floor disorders.
He made the decision to start Renovia after being approached by a medical doctor named Dr. Sam Pulliam who wanted to be able to develop products to diagnose and treat pelvic floor disorders, something that impacts around 13 million women in the United States alone. Dr. Sam Pulliam and Dr. Jose Bohorquez wanted to develop a different approach to pelvic floor disorders that didn’t involve surgery and this was the basis of starting Renovia. Marc Beer then helped these doctors get the funding that they needed for the first round of research and development. After the idea and evidence were presented, Marc Beer was convinced to start the company.
Renovia is still in its very early stages and has not been able to turn a profit just yet, but Marc Beer says that this is a normal part of the business process as they are still very new as a company. While they may not be profitable just yet, Marc Beer was able to gather another considerable round of financing for the business to get more products from their pipeline completed and taken to market where they can help the women who have these disorders and are looking for options that don’t involve surgery. Renovia has some dedicated and intelligent people as part of their team and he has confidence in what his company has to offer both patients and investors. He predicts that it will start being profitable in around a decade after it was first formed.
When it comes to marketing, things are done a bit differently than with other products. In the end, Marc Beer states that a prescription is needed which is why most of the marketing is done directly to medical professionals and not the patient themselves. In order to do this, they have paid for outreach programs and they are ready to change the approach they are using whenever it may or may not be needed. Learn more: http://inspirery.com/interview-with-marc-beer/